Prior Analysis | ||||
---|---|---|---|---|
 | PCE EXPOSURE LEVEL | |||
Latency period (years) | ≤Median | >Median | >75th Percentile | >90th Percentile |
0 | Â | Â | Â | Â |
Case/control | 91/109 | 100/108 | 59/54 | 18/21 |
COR (95% CI) | 1.2 (0.9-1.6) | 1.4 (1.0-1.8) | 1.6 (1.1-2.3) | 1.3 (0.7-2.4) |
AOR (95% CI) | 1.0 (0.7-1.3) | 1.2 (0.9-1.7) | 1.6 (1.1-2.4) | 1.3 (0.7-2.6) |
5 | Â | Â | Â | Â |
Case/control | 79/82 | 75/81 | 50/40 | 17/16 |
COR (95% CI) | 1.4 (1.0-2.0) | 1.4 (1.0-1.9) | 1.8 (1.2-2.8) | 1.6 (0.8-3.1) |
AOR (95% CI) | 1.1 (0.8-1.5) | 1.3 (0.9-1.8) | 1.6 (1.0-2.6) | 1.5 (0.7-3.0) |
7 | Â | Â | Â | Â |
Case/control | 59/68 | 69/67 | 46/33 | 17/13 |
COR (95% CI) | 1.3 (0.9-1.8) | 1.5 (1.1-2.1) | 2.0 (1.3-3.2) | 1.9 (0.9-4.0) |
AOR (95% CI) | 0.9 (0.6-1.3) | 1.3 (0.9-1.9) | 1.8 (1.1-2.9) | 1.7 (0.8-3.6) |
9 | Â | Â | Â | Â |
Case/control | 48/55 | 63/55 | 40/27 | 16/11 |
COR (95% CI) | 1.3 (0.9-1.9) | 1.7 (1.2-2.4) | 2.2 (1.3-3.6) | 2.1 (1.0-4.6) |
AOR (95% CI) | 0.9 (0.6-1.4) | 1.4 (0.9-2.0) | 1.9 (1.1-3.2) | 1.9 (0.8-4.4) |
11 | Â | Â | Â | Â |
Case/control | 39/42 | 47/41 | 29/20 | 12/8 |
COR (95% CI) | 1.4 (0.9-2.1) | 1.7 (1.1-2.6) | 2.1 (1.2-3.8) | 2.2 (0.9-5.4) |
AOR (95% CI) | 1.0 (0.6-1.5) | 1.4 (0.9-2.1) | 1.8 (1.0-3.3) | 1.8 (0.7-4.8) |
13 | Â | Â | Â | Â |
Case/control | 35/26 | 30/26 | 17/13 | 8/5 |
COR (95% CI) | 2.0 (1.2-3.3) | 1.7 (1.0-2.9) | 1.9 (0.9-4.0) | 2.3 (0.8-7.2) |
AOR (95% CI) | 1.4 (0.8-2.3) | 1.3 (0.8-2.3) | 1.6 (0.7-3.5) | 1.7 (0.5-5.2) |
15 | Â | Â | Â | Â |
Case/control | 26/18 | 18/17 | 12/8 | 2/3 |
COR (95% CI) | 2.1 (1.2-3.9) | 1.6 (0.8-3.0) | 2.2 (0.9-5.4) | 1.0 (0.2-5.9) |
AOR (95% CI) | 1.5 (0.8-2.8) | 1.1 (0.6-2.3) | 1.7 (0.7-4.3) | - |
17 | Â | Â | Â | Â |
Case/control | 11/11 | 10/10 | 4/5 | 1/2 |
COR (95% CI) | 1.5 (0.6-3.4) | 1.5 (0.6-3.5) | 1.2 (0.3-4.4) | 0.7 (0.1-8.1) |
AOR (95% CI) | 1.0 (0.4-2.4) | 1.0 (0.4-2.6) | 0.9 (0.2-3.4) | - |
19 | Â | Â | Â | Â |
Case/control | 6/5 | 3/4 | 2/2 | 0/0 |
COR (95% CI) | 1.8 (0.5-5.8) | 1.1 (0.2-4.9) | 1.5 (0.2-10.4) | - |
AOR (95% CI) | 1.3 (0.4-4.2) | 0.9 (0.2-4.1) | - | - |
Current analysis | ||||
 | PCE EXPOSURE LEVEL | |||
Latency period (years) | < Median | >Median | >75th Percentile | >90th Percentile |
0 | Â | Â | Â | Â |
Case/control | 224/324 | 225/324 | 123/162 | 56/64 |
COR (95% CI) | 1.0 (0.8-1.2) | 1.0 (0.8-1.2) | 1.1 (0.8-1.4) | 1.2 (0.8-1.8) |
AOR (95% CI) | 0.9 (0.8-1.2) | 1.0 (0.8-1.3) | 1.1 (0.9-1.5) | 1.3 (0.9-1.9) |
5 | Â | Â | Â | Â |
Case/control | 193/276 | 206/276 | 104/138 | 53/55 |
COR (95% CI) | 1.0 (0.8-1.2) | 1.0 (0.8-1.3) | 1.0 (0.8-1.4) | 1.3 (0.9-2.0) |
AOR (95% CI) | 0.9 (0.7-1.2) | 1.1 (0.9-1.4) | 1.1 (0.8-1.5) | 1.4 (0.9-2.1) |
7 | Â | Â | Â | Â |
Case/control | 176/248 | 189/248 | 101/124 | 51/49 |
COR (95% CI) | 1.0 (0.8-1.3) | 1.0 (0.8-1.3) | 1.1 (0.8-1.5) | 1.5 (1.0-2.2) |
AOR (95% CI) | 1.0 (0.8-1.3) | 1.1 (0.9-1.4) | 1.1 (0.8-1.5) | 1.4 (0.9-2.2) |
9 | Â | Â | Â | Â |
Case/control | 148/218 | 171/218 | 89/109 | 47/43 |
COR (95% CI) | 1.0 (0.7-1.2) | 1.1 (0.9-1.4) | 1.1 (0.8-1.5) | 1.5 (1.0-2.4) |
AOR (95% CI) | 1.0 (0.7-1.2) | 1.1 (0.8-1.3) | 1.1 (0.8-1.5) | 1.4 (0.9-2.2) |
11 | Â | Â | Â | Â |
Case/control | 122/188 | 159/188 | 75/94 | 40/37 |
COR (95% CI) | 0.9 (0.7-1.2) | 1.2 (0.9-1.5) | 1.1 (0.8-1.5) | 1.5 (1.0-2.5) |
AOR (95% CI) | 0.9 (0.7-1.2) | 1.1 (0.8-1.4) | 1.0 (0.7-1.4) | 1.4 (0.9-2.4) |
13 | Â | Â | Â | Â |
Case/control | 106/163 | 136/162 | 73/81 | 37/32 |
COR (95% CI) | 0.9 (0.7-1.2) | 1.2 (0.9-1.5) | 1.2 (0.9-1.7) | 1.7 (1.0-2.7) |
AOR (95% CI) | 0.9 (0.7-1.2) | 1.0 (0.8-1.4) | 1.1 (0.8-1.6) | 1.5 (0.9-2.5) |
15 | Â | Â | Â | Â |
Case/control | 85/115 | 101/114 | 50/57 | 20/22 |
COR (95% CI) | 1.0 (0.8-1.4) | 1.2 (0.9-1.6) | 1.2 (0.8-1.8) | 1.3 (0.7-2.4) |
AOR (95% CI) | 1.0 (0.7-1.3) | 1.0 (0.7-1.3) | 1.0 (0.7-1.5) | 1.0 (0.5-1.9) |
17 | Â | Â | Â | Â |
Case/control | 61/71 | 69/70 | 31/35 | 18/14 |
COR (95% CI) | 1.2 (0.8-1.7) | 1.3 (0.9-1.9) | 1.2 (0.7-2.0) | 1.7 (0.8-3.5) |
AOR (95% CI) | 0.9 (0.6-1.3) | 1.0 (0.7-1.5) | 0.9 (0.5-1.5) | 1.3 (0.6-2.7) |
19 | Â | Â | Â | Â |
Case/control | 34/40 | 50/38 | 19/19 | 9/7 |
COR (95% CI) | 1.1 (0.7-1.8) | 1.8 (1.1-2.7) | 1.3 (0.7-2.6) | 1.7 (0.6-4.7) |
AOR (95% CI) | 0.8 (0.5-1.3) | 1.3 (0.8-2.0) | 1.0 (0.5-2.0) | 1.3 (0.5-3.6) |